1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Ending the HIV Epidemic: Clinical Trials Networks - Leadership and Operations Center (LOC) is sponsored by National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID). Supports clinical trials networks and community implementation research designed to advance HIV prevention, treatment, and support frameworks under the federal Ending the HIV Epidemic initiative.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the opportunity page linked on this listing to help you evaluate fit faster.
Opportunity Listing - HIV/AIDS Clinical Trials Network Leadership and Operations Centers Simpler. Grants. gov uses Login.
gov to verify your identity and manage your account securely. You don't need a separate username or password for this site. HIV/AIDS Clinical Trials Network Leadership and Operations Centers Agency: National Institutes of Health 93.
310 -- Trans-NIH Research Support 93. 855 -- Allergy and Infectious Diseases Research Forecasted Forecasted opportunity Last Updated: May 13, 2026 View version history on Grants.
gov The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance the National Institutes of Health (NIH) mission by supporting four Clinical Trials Networks (CTNs) each comprised of a Leadership and Operations Center (LOC), Statistical and Data Management Center, and Laboratory Center working with Clinical Trials Units to advance prevention, treatment, and implementation research designed to end the HIV epidemic.
This NOFO will solicit applications for four LOCs to provide scientific leadership, research prioritization, and conduct studies in a CTN.
A LOC develops the research agenda in one of these areas: 1) HIV therapeutics/cure, and prevention/treatment for HIV-associated comorbidities in adults; 2) HIV prevention/treatment in maternal/adolescent/pediatric populations; 3) biomedical HIV prevention strategies for adults/adolescents; and 4) immune-based prevention for HIV and HIV-associated diseases.
CTNs will conduct HIV implementation research improving uptake of evidence-based prevention and treatment strategies across the lifespan. High impact LOC studies will produce crucial findings significantly benefiting Americans with or at-risk of HIV and HIV-associated diseases.
Grant authorities that allow NIAID to forecast this opportunity are: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
For-profit organizations other than small businesses Federally recognized Native American tribal governments Special district governments Public and Indian housing authorities City or township governments Independent school districts Public and state institutions of higher education Private institutions of higher education Other Native American tribal organizations Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.
Grantor contact information Please contact via e-mail. No documents are currently available. Link to additional information Estimated Application Due Date : Estimated Due Date Description : Estimated Project Start Date : Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Nonprofits having a 501(c)(3) status with the IRS, community-based organizations, and health service providers. Confirm the full requirements in the official notice before applying.
Applications for Ending the HIV Epidemic: Clinical Trials Networks - Leadership and Operations Center (LOC) are due January 22, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Ending the HIV Epidemic: Clinical Trials Networks - Leadership and Operations Center (LOC) is funded by National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleRFA-AI-28-005 recompetes NIAID's Immune Tolerance Network as a single UM1 cooperative agreement: $27M committed in FY2028, budgets capped at $23M a year in direct costs, a mandatory 7-year project period, one application per institution, and a January 29, 2027 deadline. The winner inherits roughly 20 ongoing trials and about 200 sub-agreements.
Read articleNIAID's RFA-AI-28-024 funds preclinical malaria vaccines, from AI-guided design to cGMP lots, through a phased R61/R33. It allows one application per institution, bars foreign subawards, and excludes GLP tox.
Read article